We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Great Ormond Street Hospital to Build New Research Facility

By HospiMedica International staff writers
Posted on 20 Dec 2016
Great Ormond Street Hospital for Children (GOSH; London, United Kingdom) and University College London (UCL; United Kingdom) are constructing a new, state-of-the-art research center.

The Zayed Centre for Research into Rare Diseases in Children will be built adjacent to GOSH and the UCL Institute of Child Health, and will provide cutting-edge technology, equipment, and office space for up to 400 world-leading scientists and clinicians. More...
The center will contain a variety of research laboratories to study rare diseases and develop treatments. A good manufacturing practice (GMP) facility on the fourth floor will aid laboratories to manufacture specialist products for new therapies, clinical trials, and patient treatments.

The six-story building will have a total floor space of more than 13,000m², with equipment rooms and workspaces to develop diagnostic procedures, manufacture gene and cell therapies, and to create personalized medical devices. Additional features will include a cardiology suite; a flow cytometry suite for the counting, storing, and analysis of cells with laser technology; a new outpatient clinic; and research write-up areas, meeting rooms, and spaces to allow scientists and medical teams to collaborate and progress with their work. Two large laboratories will be located on the lower ground floor.

“The really exciting thing about the new building is the possibility of creating a working environment that brings everyone together. As a clinician, I need to explore my options for treating a patient with experts who can help me develop them,” said Professor Andrew Taylor, MD, of GOSH and UCL. “A variety of different professionals under one roof will allow us to turn innovative thinking into practical solutions. The centre will also give us a manufacturing capacity to develop these solutions at scale so we can help more and more patients.”

The new research center, named in the honor of Sheikh Zayed bin Sultan Al Nahyan, the Emir of Abu Dhabi and first president of the United Arab Emirates (UAE), will operate as a partnership between Great Ormond Street Hospital, UCL, and the Great Ormond Street Hospital Children’s Charity (London, United Kingdom). Construction is scheduled to begin in January 2017 and is expected to be completed by 2018.

Related Links:
Great Ormond Street Hospital for Children
University College London
Great Ormond Street Hospital Children’s Charity

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.